Dahu Health Industry Co., Ltd. (SHA:600257)
China · Delayed Price · Currency is CNY 5.15
+0.06 (1.18%)
Jul 31, 2026, 3:00 PM CST
Dahu Health Industry Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,478 | 3,022 | 2,271 | 2,969 | 2,883 | 3,537 | |
Market Cap Growth | -8.04% | 33.05% | -23.50% | 3.00% | -18.50% | 27.83% |
Enterprise Value | 3,047 | 3,579 | 2,947 | 3,694 | 3,777 | 4,035 |
Last Close Price | 5.15 | 6.28 | 4.72 | 6.17 | 5.99 | 7.35 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 445.14 | 596.64 | - | - | - | - |
Forward PE | - | 162.54 | 162.54 | 162.54 | 162.54 | 162.54 |
PS Ratio | 2.70 | 3.29 | 2.17 | 2.49 | 2.63 | 2.74 |
PB Ratio | 2.48 | 3.05 | 2.38 | 2.92 | 2.88 | 3.29 |
P/TBV Ratio | 4.50 | 5.32 | 4.08 | 4.85 | 4.82 | 5.64 |
P/FCF Ratio | 16.10 | 14.51 | 49.26 | 20.78 | 79.95 | 211.39 |
P/OCF Ratio | 12.64 | 13.86 | 33.67 | 18.32 | 29.46 | 36.68 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.32 | 3.89 | 2.82 | 3.10 | 3.45 | 3.12 |
EV/EBITDA Ratio | 21.63 | 36.61 | 41.41 | 44.45 | 89.52 | 61.61 |
EV/EBIT Ratio | 37.93 | 45.94 | 59.68 | 62.60 | 216.95 | 111.64 |
EV/FCF Ratio | 19.79 | 17.18 | 63.91 | 25.85 | 104.76 | 241.16 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.71 | 0.70 | 0.76 | 0.85 | 0.87 | 0.87 |
Debt / EBITDA Ratio | 5.02 | 4.97 | 6.52 | 7.14 | 10.95 | 10.46 |
Debt / FCF Ratio | 4.60 | 3.31 | 15.84 | 6.08 | 24.21 | 56.17 |
Net Debt / Equity Ratio | 0.37 | 0.33 | 0.53 | 0.50 | 0.64 | 0.53 |
Net Debt / EBITDA Ratio | 3.70 | 3.30 | 7.15 | 6.16 | 15.20 | 8.75 |
Net Debt / FCF Ratio | 2.39 | 1.55 | 11.04 | 3.58 | 17.79 | 34.24 |
Asset Turnover | 0.50 | 0.50 | 0.53 | 0.56 | 0.49 | 0.60 |
Inventory Turnover | 1.55 | 1.54 | 1.79 | 1.86 | 1.67 | 1.88 |
Quick Ratio | 1.12 | 1.04 | 0.84 | 0.94 | 0.69 | 0.89 |
Current Ratio | 2.28 | 1.96 | 1.88 | 1.88 | 1.68 | 1.73 |
Return on Equity (ROE) | 3.72% | 3.42% | -6.17% | 1.21% | -7.13% | -16.64% |
Return on Assets (ROA) | 2.71% | 2.62% | 1.57% | 1.74% | 0.48% | 1.05% |
Return on Invested Capital (ROIC) | 3.40% | 3.08% | 3.30% | 1.62% | 1.06% | 2.38% |
Return on Capital Employed (ROCE) | 5.50% | 5.60% | 3.50% | 3.80% | 1.10% | 2.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.22% | 0.17% | -3.39% | -0.27% | -2.48% | -5.09% |
FCF Yield | 6.21% | 6.89% | 2.03% | 4.81% | 1.25% | 0.47% |
Payout Ratio | 194.76% | 231.09% | - | - | - | - |
Buyback Yield / Dilution | -5.39% | -5.32% | -17.90% | 14.41% | 2.09% | -1.53% |
Total Shareholder Return | -5.39% | -5.32% | -17.90% | 14.41% | 2.09% | -1.53% |